HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Schisandrin B improves cerebral ischemia and reduces reperfusion injury in rats through TLR4/NF-κB signaling pathway inhibition.

Abstract
It has been established that poor outcomes in ischemic stroke patients are associated with the post-reperfusion inflammatory response and up-regulation of TLR4. Therefore, suppression of the TLR4 signaling pathway constitutes a potential neuroprotective therapeutic strategy. Schisandrin B, a compound extracted from Schisandra chinensis, has been shown to possess anti-inflammatory and neuroprotective properties. However, the mechanism remains unclear. In the present study, the therapeutic effect of schisandrin B was assessed following cerebral ischemia and reperfusion (I/R) injury in a model of middle cerebral artery occlusion and reperfusion (MCAO/R) in rats. The effects of schisandrin B were investigated with particular emphasis on TLR4 signal transduction and on the inflammatory response. Schisandrin B treatment conferred significant protection against MCAO/R injury, as evidenced by decreases in infarct volume, neurological score, and the number of apoptotic neurons and inflammatory signaling molecules.
ABBREVIATIONS:
I/R: schemia/reperfusion; IL: interleukin; MCAO/R: middle cerebral artery occlusion and reperfusion; NF-κB: nuclear; TLR4: Toll-like receptor 4; TNF-α: tumor necrosis factor-α.
AuthorsXingjuan Fan, Kenneth Elkin, Yunwei Shi, Zhihong Zhang, Yaqin Cheng, Jingxiao Gu, Jiale Liang, Caiping Wang, Xunming Ji
JournalNeurological research (Neurol Res) Vol. 42 Issue 8 Pg. 693-702 (Aug 2020) ISSN: 1743-1328 [Electronic] England
PMID32657248 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Cyclooctanes
  • Lignans
  • NF-kappa B
  • Polycyclic Compounds
  • Tlr4 protein, rat
  • Toll-Like Receptor 4
  • schizandrin B
Topics
  • Animals
  • Anti-Inflammatory Agents (administration & dosage)
  • Brain Ischemia (complications, metabolism, prevention & control)
  • Cyclooctanes (administration & dosage)
  • Lignans (administration & dosage)
  • Male
  • NF-kappa B (metabolism)
  • Polycyclic Compounds (administration & dosage)
  • Rats, Sprague-Dawley
  • Reperfusion Injury (complications, metabolism, prevention & control)
  • Signal Transduction (drug effects)
  • Toll-Like Receptor 4 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: